The Renaissance of microbiology by Julian Davies
The science of microbiology (the study of the oldest living and
most abundant organisms on this planet) is relatively young; it
began seriously only in the mid-19th century with the work of
Pasteur and Koch. Chemistry (or at least alchemy) and physics
are more ancient scientific disciplines. All the sciences have
developed rapidly in the past one hundred years, but in particular
the explosion of new knowledge in life sciences that began
some thirty years ago and continues to increase in an
exponential manner is clearly beyond all expectation; the growth
curve resembles that of a microbe! This expansion has its basis
in advances in the techniques of genetics and molecular biology
and, more recently, the advent of nucleic acid sequencing that
has begun to reveal detailed information on gene structure and
organization on a larger scale. During the early excitement of
the Human Genome Project, the sequencing of bacterial
genomes was given little attention, despite the fact that the first
genomes completed in early sequencing efforts had been those
of microbes, the bacteriophages φx174 and λ; now, however,
the sequencing of prokaryotic genomes has moved to centre
stage and the leading laboratories of eukaryotic sequence
analysis are currently devoting much effort to the analysis of
the genomes of microbes. It is reliably predicted that by the
year 2000 there will be more than one hundred completed
bacterial genome sequences [12]. While the prospect of all this
knowledge is daunting, it should be considered appropriate
in light of the fact that this represents only a tiny fraction of
the microbial kingdom, 99.9% of which cannot be grown for
laboratory study.
This emphasis is, of course, exactly as it should be!
Microbes are the founder members of this planet and
understanding bacterial function is a first priority in biology
because of the critical role of microbes in the maintenance of
all other forms of life. If the process of evolution is to be
unravelled properly to elucidate the evolution of biosynthetic
pathways and their regulation, complete bacterial genome
sequences are obligatory to furnish the predictive information
essential for functional genomic studies of more complex
genomes, since gene identification and organization in higher
organisms will be derived principally from comparative studies
with simpler genomes.
At the time of writing, some twenty microbial genome
sequences have been completed (although not necessarily
annotated) and are in the process of more detailed analysis;
clearly this work will keep microbiologists busy for some time.
The nucleotide sequences of fifty other microbial genomes are
well advanced, and the continuation of these efforts will result
in the completion of the sequences of most of the major classes
of bacteria, archaea and lower eukaryotes within 5 years. In
addition, current commercial databases have been estimated
to contain two- to three-fold more bacterial sequence
information, which is not available to the scientific community.
For much of this latter it is not known what organisms have
been sequenced or the quality of the data. (It is regrettable that
industry benefits from all of the publicly funded sequence
information from academia [such as the yeast genome] but
provides little in return.) Be that as it may, the publicly available
sequences have provided new knowledge that whets the appetite
for more, even though the analytical approaches (functional
genomics) being used to obtain useful biological conclusions
from these sequences are still fairly primitive. 
What has been learned from this information so far? First
and foremost is the finding that, depending on the organism,
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as much as 30% of the open-reading-frame sequences are
essentially uninterpretable, since they do not match the genes
thus far identified in the available databases; this is both exciting
and frustrating and underlines the need to develop the methods
that can be used to predict protein function from DNA sequence
information. Nonetheless, many interesting conclusions with
respect to overall chromosome organization, biosynthetic
pathways and their regulation have been revealed. (For
examples, see references [3, 6, 11].) With the number of
sequenced genomes increasing comparative studies have
become more reliable, providing information on specific
functions, as mentioned below. There are other constraints
on the use of nucleotide sequence information. In most cases,
in order to simplify the assignment and analysis of genetic
organization, it has been considered necessary to restrict the
minimum length of identified open reading frames to 50–100
amino acids; it is thus likely that many functions important
to microbial life will not be identified during this first phase of
the sequencing revolution. Small bacterial peptides and their
derivatives are being overlooked, for example molecules of the
microcin type, which are probably made by most bacteria and
play roles in many aspects of the biology of microbial
interactions [2]. The comparative analyses of the sequences of
housekeeping genes are proving to be invaluable in establishing
detailed phylogenetic trees, and initial work has uncovered
several surprises that will influence our thinking on the evolution
of genome function. It is evident that improved methods of
protein domain identification and more sophisticated pattern
tools will be needed if raw nucleotide sequences are to be
interpreted to their full extent. For example, how does one
predict the function of novel RNA genes?
At the present time, comparative (subtractive) analyses of
closely related species are proving to be the most productive;
for example, the identification and study of pathogenicity
islands is an exciting area of investigation that is revealing
new concepts of microbial behavior [14]. Simply described,
since the difference in properties between a pathogen and a
non-pathogen of the same bacterial species must lie in
nucleotide sequence differences, subtractive analysis should
identify those sequences involved in specific steps of
pathogenesis; in addition, differences in G+C content, coding
preferences or similar variations can provide evidence
suggestive of horizontal gene transfer. The demonstration that
genes responsible for virulence functions (toxins, adhesion
and binding factors, specific secretion mechanisms, etc.) are
found in discrete clusters on bacterial chromosomes and are
clearly of foreign origin is of great significance in studying
the evolution of pathogens and the molecular mechanisms
of the process of host/pathogen interactions [8, 13, 22]. While
the utility of the discovery of “pathogene” clusters to identify
new targets for drug discovery remains untested at the time of
writing, there is good reason to believe that future study of
agents that can interfere with functions involved in
host/pathogen interactions may lead to novel types of therapy.
Possibilities include classes of therapeutic compounds that do
not interfere with normal growth of the organism but rather
turn off those functions that give the pathogen its foothold
in infection (disarmament rather than killing), thus permitting
the immune defences of the host to destroy a microbe that
no longer has a survival advantage in the host. The work of
Balaban et al. has given encouragement that this approach
could be successful in some cases [1]. One obvious benefit of
this type of agent would be that selection for antibiotic
resistance might be less severe, although it is likely that the
use of any agent capable of reducing the competitive survival
(growth) of a microbe in a particular environment would still
provide a selection for mechanisms of avoidance. Microbes
are the ultimate survivors! However, should this approach
prove successful, there is a significant operational difficulty:
it will run counter to several generations of medical
pharmaceutical schooling in the treatment of infectious disease,
in particular the rationale for the use of broad-spectrum
antimicrobial therapy with cidal agents. How readily would
such a radical, new approach be accepted?
Comparative genomic analysis is likely to identify numerous
other ‘islands’ or ‘islets’ of genetic information related to
specific properties of the organism. For the study of antibiotic
resistance, for instance, it should become possible to identify
antibiotic resistance genes and their clusters on the basis of
association with common elements such as attachment sites or
integrases; these genes are most often found in linked and often
co-regulated groups [15, 18]. Also, improvements in the process
of gene-protein identification will provide clues concerning
the origins and evolution of resistance and make it possible
to predict ‘new’ antibiotic resistance genes directly from the
scrutiny of nucleotide sequence data.
An additional benefit of sequence comparisons of genomes
will be the possibility to identify gene clusters encoding the
pathways for catabolism of xenobiotic degradation and also
pathways responsible for the biosynthesis of secondary
metabolites. As the nucleic acid sequences of more of the
complex bacteria (streptomycetes, myxococci, etc.) are
determined, such comparative analyses should permit the
identification of novel degradative and biosynthetic gene
clusters. In most cases these might be expected to be present
as genetic ‘islands’, distinguished from flanking DNA sequences
in codon usage, regulatory organization, etc. Identification of
such modules may then lead to the isolation (possibly by
surrogate host expression) of novel bioactive secondary
metabolites that have therapeutic value. As an indication of the
power of this technique, one early result of the Streptomyces
coelicolor genome project has been the complete structural
characterisation of the biosynthetic cluster for
undecylprodigiosin (the red cluster) [5]. As more of these
clusters are picked out, the description of the complex regulatory
processes involved in control of biosynthetic pathways for small
molecules will aid in the rational engineering of secondary
metabolite production levels for industrial uses.
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The production of secondary metabolites is typical of many
different microbial genera and species (perhaps all?), but their
synthesis and functions are poorly characterized; the application
of comparative genomics to the identification of the biosynthetic
pathways, their potential products and their functions in the
physiology of the producing organism is an exciting prospect.
How easily will this be achieved? The gene clusters are highly
specialized, but it should be possible to distinguish them from
those encoding the housekeeping or essential cell functions
using the same approaches that are being employed to detect
other unique characteristics such as pathogenicity, as mentioned
earlier. Obviously, dramatic advances in the ability to analyze
nucleotide sequences within the context of entire genomes and
predict their biochemical roles (functional genomics) will be
required. This will not necessarily be an easy process since, if
we take the microcins of E.coli as an example, the gene
encoding the basic peptide structure would likely be missed
under the search parameters currently used; the genes involved
in post-translational modification would be difficult to identify
unless particular types of gene organization are being sought.
The identification of the previously unknown L-idonate
metabolic pathway in E. coli is an interesting portent for the
future of this type of study [20].
As differential genome sequence analysis becomes more
sophisticated, there is little doubt that many examples of
horizontal gene transfer at the inter- and intra-genic and
species level will be uncovered. This is to be expected, since
studies indicate that gene transfer is a significant factor in
genome evolution for housekeeping and specialized functions
[24]. For example, in the case of secondary metabolites, there
is suggestive evidence for the horizontal transfer of the gene
clusters required for β-lactam biosynthesis between bacteria
and fungi [7]; it can be anticipated that this will be the case
for many other biosynthetic pathway clusters. Such findings
will engender questions as to what mechanisms of transfer
are involved and what will be the organismal limits of the
various types of gene exchange? Might there be novel types
of transfer?
Since low-molecular-weight compounds are presumed to
play important roles in maintaining microbial communities,
their cognate biosynthetic pathways must be under the control
of sensing mechanisms for cell density and a variety of stressful
environmental changes. What role(s) will global regulatory
systems play in these cases? To date, a number of peptide-
signalling agents have been identified in microbial
developmental cycles and also in the lifestyles of certain
bacterial pathogens; it is not unreasonable to suggest that
polyketides, nucleosides, sugars, and hybrids between these
structures will also play roles in the maintenance of microbial
community life [16]. A bacterial cytokine (protein) has recently
been identified [19], and it will be important to unravel the
processes involved in the function of informational molecules
of this type, not only for what they reveal about the life-styles
of single-celled organisms, but also as potential evolutionary
precursors of the complex regulatory and controlling processes
in higher eukaryotes, such as those of hematopoiesis and the
immune system.
It is of interest to note that, in recent years, many so-called
‘eukaryotic’ processes (such as tyrosine- and serine-threonine
kinases and their associated phosphatases as well as calmodulin-
based regulation, to name just a few) have been identified in
prokaryotes [17, 25] and have been shown to play critical roles
in cell development and host/pathogen interactions [4, 10].
Conversely, the histidine-aspartyl-kinase two-component
signalling processes (typically ‘prokaryotic’) have been
identified in eukaryotes [17]. If truth be known, all such
biochemical processes are ‘prokaryote-like’. Suggesting that
these functions are specific to any genus or species is non-
productive, since they are all related through cellular evolution.
It is to be expected that common post-translational processes
will exist throughout biology and an evolutionary approach
will be essential to provide an understanding of cellular
biochemistry and behavior; as increasing nucleotide sequence
becomes available, it can be predicted that more universal
functions will be identified. Jacques Monod once proposed that
when we understand E. coli we will understand elephants; this
prophecy, in a general sense, now seems plausible. The notion
that a ‘pool’ of progenotes (rather than a single universal
progenitor) was the likely basis for cellular evolution, coupled
with evidence of extensive horizontal gene transfer during the
evolution of genera and species indicates that the evolution of
living cells has the characteristics of a chaotic process and needs
to be considered in this way.
Finally, returning once more to the subject of secondary
metabolism, the function of these processes and their many
products in microbial ecology remains largely a mystery and
is now ripe for more detailed investigation. As mentioned
previously, new studies of non-cultivable organisms and
comparative genomic analyses will probably unmask new
classes and types of products. While there is definite evidence
for a ‘true’ antibiotic role in certain circumstances (especially
in plant/bacterial relationships and protection against infection),
the enormous number and variety of microbial secondary
metabolites produced by microbes provoke many questions
and call for further analysis of their natural functions. Many
activities and roles for secondary metabolism (in one sense the
most creative form of cellular metabolism) have been suggested
[9], but few convincing experiments have been carried out;
obviously the experiments are not easy! Given the fact that
microbes always grow in communities—a certainty that is
becoming increasingly apparent to present-day microbiologists—
it is reasonable to assume that these communities, such as
biofilms, soils and other macro- and micro-ecosystems, must
sustain their structural and metabolic stability through
microbe/microbe interactions involving (principally) low-
molecular-weight compounds as the intermediates for inter-
and intra-cellular cross-talk and regulation [21]. More attention
to the subject of ‘social microbiology’ should reveal novel 
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Table 1 Why study microbial diversity?
1. Explore the environmental limits of life.
2. Establish the organismal requirements for biosphere sustainability.
3. Provide new resources for biotechnology, pharmaceuticals, energy
production, waste treatment.
4. Monitor and predict environmental change, understand global chemical
cycling.
5. Broaden conservation biology and bioremediation.
6. Test community ecology principles.
7. Obtain records of early eras—evolutionary relationships and mechanisms
(e.g., horizontal gene transfer) and their role in the evolution and
maintenance of the biosphere.
8. Study gene transfer in nature: environmental safety, fate of released DNA,
survival of introduced microbes. Examine the extent of natural gene
exchange.
9. Define and prevent harmful microbial activities such as corrosion,
biofouling, fertilizer degradation.
10. Expand knowledge of the gene pool.
11. Identify the nature of pathogenicity and other host-parasite relationships.
12. Understand the sociobiology of microbial communities and their
maintenance.
aspects of the chemical interactions (hypothesized to be mostly
synergistic) between microbes in nature.
This is a very good time to be a microbiologist. The ability
to grow single bacterial colonies on solid medium, developed
by Robert Koch in 1881, was a critical discovery in the
development of microbiological science, but one which, for
more than a century, has focused the efforts of the majority
of microbiologists on studying microbes as single colony entities
and not as complex communities. The vast array of powerful
technical methods available for the study of all aspects of
microbial growth, coupled with the benefits of complete
microbial genome sequences, has now put microbiology in its
“place as the fundamental discipline of all biology” [23].
Employing and interpreting the accumulating information and
applying the derived knowledge to the broader questions of
evolution, disease, and the functions of microbial diversity in
all aspects of life on earth will entail an enormous amount of
work. Perhaps more than anything, concerted efforts to
understand the full nature of microbial diversity (Table 1), its
genetics, biochemistry and control, will earn the most substantial
dividends for the future of biology.
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